Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-312

4 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 68083-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin-carton-label (Tobramycin Carton Label)

Tobramycin-carton-label (Tobramycin Carton Label)
Label for Tobramycin for Injection, USP, 1.2 grams per vial, injection powder lyophilized for intravenous use. The package contains 6 vials of 1.2 g each and is manufactured by Gland Pharma Limited. Label includes preparation, storage instructions, and a barcode. Marked as pharmacy bulk package not for direct infusion.*
FDA Label Image

Tobramycin-container-label (Tobramycin Container Label)

Tobramycin-container-label (Tobramycin Container Label)
Label for Tobramycin for Injection, USP 1.2 grams per vial, lyophilized powder for injection. It is a pharmacy bulk package, labeled "Not for direct infusion" and intended for intravenous use. The label includes preparation instructions, storage conditions, and states the container closure is not made with natural rubber latex. Manufactured by Gland Pharma Limited, Hyderabad, India. NDC 68083-312-01.*
FDA Label Image

Tobramycin-nomogram (Tobramycin Nomogram)

Tobramycin-nomogram (Tobramycin Nomogram)
A line graph illustrating a reduced dosage nomogram for Tobramycin injection, powder, lyophilized, for solution. The x-axes indicate serum creatinine levels (mg/100 mL) and creatinine clearance (mL/min/1.73 m²), while the y-axis shows percent of normal dosage from Table 3. The graph depicts a direct linear relationship between these variables, supporting dosage adjustments based on renal function.*
FDA Label Image

Tobramycin-structure (Tobramycin Structure)

Tobramycin-structure (Tobramycin Structure)
Chemical structure of Tobramycin, showing the molecular arrangement of its amino sugar components and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.